Evidence map›Paper›PMID 38291121›Full record

ArticleScientific reports2024

Artificial intelligence assisted patient blood and urine droplet pattern analysis for non-invasive and accurate diagnosis of bladder cancer.

Ramiz Demir, Soner Koc, Deniz Gulfem Ozturk, Sukriye Bilir, Halil İbrahim Ozata, Rhodri Williams, John Christy, Yunus Akkoc, İlker Tinay, Cigdem Gunduz-Demir and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ramiz DemirKoç University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey.
Soner KocDepartment of Computer Engineering, Koç University, Istanbul, Turkey.
Deniz Gulfem OzturkKoç University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey.
Sukriye BilirSUNUM Nanotechnology Research and Application Center, Istanbul, Turkey.
Halil İbrahim OzataDepartment of Surgery, Koç University, Istanbul, Turkey.
Rhodri WilliamsSchool of Engineering, University of Edinburgh, Edinburgh, UK.
John ChristySchool of Engineering, University of Edinburgh, Edinburgh, UK.
Yunus AkkocKoç University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey.
İlker TinayAnadolu Medical Center, Gebze, Kocaeli, Turkey.
Cigdem Gunduz-DemirDepartment of Computer Engineering, Koç University, Istanbul, Turkey. cgunduz@ku.edu.tr.
Devrim GozuacikKoç University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey. dgozuacik@ku.edu.tr.

Funding

Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 216S915
6 · The paper itself

Abstract

Bladder cancer is one of the most common cancer types in the urinary system. Yet, current bladder cancer diagnosis and follow-up techniques are time-consuming, expensive, and invasive. In the clinical practice, the gold standard for diagnosis remains invasive biopsy followed by histopathological analysis. In recent years, costly diagnostic tests involving the use of bladder cancer biomarkers have been developed, however these tests have high false-positive and false-negative rates limiting their reliability. Hence, there is an urgent need for the development of cost-effective, and non-invasive novel diagnosis methods. To address this gap, here we propose a quick, cheap, and reliable diagnostic method. Our approach relies on an artificial intelligence (AI) model to analyze droplet patterns of blood and urine samples obtained from patients and comparing them to cancer-free control subjects. The AI-assisted model in this study uses a deep neural network, a ResNet network, pre-trained on ImageNet datasets. Recognition and classification of complex patterns formed by dried urine or blood droplets under different conditions resulted in cancer diagnosis with a high specificity and sensitivity. Our approach can be systematically applied across droplets, enabling comparisons to reveal shared spatial behaviors and underlying morphological patterns. Our results support the fact that AI-based models have a great potential for non-invasive and accurate diagnosis of malignancies, including bladder cancer.

Indexed as

Artificial IntelligenceUrinary Bladder NeoplasmsBiomarkers, TumorHumansReproducibility of ResultsUrinary BladderBiomarkers, Tumor

Identifiers

PMID38291121
PMCPMC10827787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.